NCT06863701View on ClinicalTrials.gov

Efficacy Anda Safety of Etoricoxib With Betamethasone for the Treatment of Acute Gout Arthritis

PHASE3RecruitingINTERVENTIONAL
Enrollment

72

Participants

Timeline

Start Date

January 27, 2025

Primary Completion Date

December 31, 2026

Study Completion Date

January 31, 2027

Conditions
Gout ArthritisGout Attack
Interventions
DRUG

Etoricoxib + Betamethasone fixed dose

One tablet of 90 mg / 0.25 mg a day

DRUG

Etoricoxib fixed dose

One pill of 90 mg a day

Trial Locations (1)

11000

RECRUITING

Laboratorio Silanes, S.A. de C.V., Mexico City

All Listed Sponsors
lead

Laboratorios Silanes S.A. de C.V.

INDUSTRY